Meaning-Centered Psychotherapy Training for Cancer Care Providers

The purpose of this project, entitled "Meaning-Centered Psychotherapy Training for Cancer Care Providers," is to develop a multi-modal training program in Meaning-Centered Psychotherapy (MCP) for multidisciplinary cancer care clinicians who provide psycho-oncology and psychosocial palliative care services for cancer patients.

Study Overview

• Status: Active, not recruiting
• Conditions: Cancer Care Providers
• Intervention / Treatment: Behavioral: workshop; Behavioral: follow-up calls & webinars; Behavioral: assessments

• Study Type: Observational
• Enrollment (Actual): 350

Contacts and Locations

Study Locations

• United States
  • New York
    • New York, New York, United States, 10065
      • Memorial Sloan Kettering Cancer Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 21 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

• Sampling Method: Non-Probability Sample

Study Population

clinicians (20% MSKCC providers & 80% outside providers)

Description

Inclusion Criteria:

• Clinicians who provide psycho-oncology and/or psychosocial palliative care services for to patients with cancer and/or severe medical illness/disease at MSKCC, other institutions, or in the community, as per self-report.
• Completed online MCPT application form and commits to attend the two-day intensive MCPT program, complete training follow-up assessments, and participate in required follow-up training activities.
• Able to speak, read, and understand English proficiently to participate in MCPT training sessions and complete assessments.

Exclusion Criteria:

• Does not meet the criteria of an appropriate candidate for training program, as determined by review of the MCPT Application Evaluation Checklist in the opinion of the investigator.

  • Materials for the training and the training will be conducted in English only.

Study Plan

How is the study designed?

Design Details

• Observational Models: Cohort
• Time Perspectives: Prospective

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Cancer Care Providers; Provider will attend a MCPT two-day intensive workshop that will include: Didactic Components; Experiential Exercises; Simulated patient role plays with actors; Provider completes MCPT Workshop Assessment MCPT POST-WORKSHOP IMPLEMTATION (OPTIONAL); MCP Core Competency Trainer rated Assessment; MCP Pre & Post Workshop Knowledge Assessment; MCPT Session Evaluation Assessment Provider will participate in training follow-up calls & webinars for approximately 6 -12 months following completion of MCPT workshop.; Provider will have ongoing access to MCPT Website with a discussion board, training resources and materials for clinical care.; Provider will complete follow-up assessment at 3, 6, 9, & 12 months post-training; Training Update; Goal Evaluation Form; MCP Core Competency Self-Assessment MCPT POST-WORKSHOP IMPLEMTATION (OPTIONAL)

Behavioral: workshop; Behavioral: follow-up calls & webinars; Behavioral: assessments

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
participant's skills uptake at the end of the MCPT session score range 0-10	Evaluation will take place on two levels, as data will be collected directly from: 1) MCPT participants and 2) MCP trainers. Data on the training will be collected before and during the MCPT session. Data on post-MCP training will be collected for one year following participation in the MCPT.	change from Baseline to 12 months

Collaborators and Investigators

• Sponsor: Memorial Sloan Kettering Cancer Center
• Collaborators: Massachusetts General Hospital; University of Pennsylvania; Northwestern University; Dana-Farber Cancer Institute; City of Hope Medical Center; Stanford University; New York Presbyterian Hospital; MJHS Institute for Innovation in Palliative Care; Odette Cancer Center - Sunnybrook Hospital; VA New York Harbor Healthcare System; Smilow Cancer Hospital - Yale New Haven Health; Department of Veterans Affairs, New Jersey; Vidant Cancer Care
• Investigators: Principal Investigator: William Breitbart, MD, Memorial Sloan Kettering Cancer Center

Publications and helpful links

Helpful Links

• Memorial Sloan Kettering Cancer Center

Study record dates

Study Major Dates

• Study Start (Actual): December 11, 2015
• Primary Completion (Estimated): December 11, 2024
• Study Completion (Estimated): December 11, 2024

Study Registration Dates

• First Submitted: March 15, 2016
• First Submitted That Met QC Criteria: March 31, 2016
• First Posted (Estimated): April 6, 2016

Study Record Updates

• Last Update Posted (Estimated): November 21, 2023
• Last Update Submitted That Met QC Criteria: November 20, 2023
• Last Verified: November 1, 2023

More Information

Terms related to this study

• Keywords: Cancer Care Providers; Psychotherapy; 15-321
• Other Study ID Numbers: 15-321

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No